BACKGROUND: Postoperative lymphatic complications are not common, and lymphatic leakage complication post appendectomy (LLCPC) is even rarer. However, the number of this operation is high so LLCPC can occur.
Introduction
Postoperative lymphatic complications include the phenomena according to a recent review: lymphocele, lymph ascites, lymphorrhea, lymphatic fistula, chylous ascites, chylothorax, chyloretroperitoneum and chylorrhea [1] . Most lymphatic leakages can be spontaneously healed without the need for intervention; the priority treatment is conservative treatment including drainage, parenteral nutrition along with the use of somatostatin [1] , [2] . However, to some death threatening cases, prompt treatments are required [2] , [3] . Various causes have been recognized as the obstacles of operated obliteration of lymphatic leakage: 1) lymphatic vessels seem to be "invisible" on macroscopic anatomy in surgery; 2) high anatomic variations between patients; 3) lymphatic injury has various types without a common treatment for each type; 4) understandings about lymphatic anatomy has been still limited [2] , [3] , [4] .
The improvement of ultrasound-guided intranodal lymphangiography has disclosed various forms of lymphatic injury, which is favourable for the strategies of treatment [4] . Recently, the percutaneous intervention has been applied to postoperative lymphatic injury with the support of imaging modalities including fluoroscopy and computerised tomography (CT) [2] , [4] , [5] , [6] .
Here, we report a rare case of a patient with lymphatic leakage after appendectomy.
Case Report
A thirty-three-year-old Vietnamese female with normal medical history after appendectomy due to appendicitis had her abdomen swollen quickly. Ultrasound examination revealed that she had a large amount of abdominal fluid and right pleural effusion. The colour and biochemical results of fluid sampling by fine needle aspiration confirmed that she had chylous ascites and right chylothorax. She was then followed by six different surgeries including thoracic open and abdomen surgical opening to ligate the lymphatic vessels and the thoracic duct, but all approaches were failures.
The patient came to our hospital with abdominal distention and physical exhaustion. Ultrasonography and computed tomography revealed a large amount of free abdominal fluid and right pleural cavity ( Figure 1A ). About 5 litres of ascites (Pigtail 6Fr-Biotech) drained out as milky white fluid ( Figure 1B ). Biochemical tests of the drainage fluid showed a very high concentration of triglyceride (7.1 mmol/l). Lymphangiography was performed using an intranodal technique using system DSA with contrast injection to lymph nodes at both inguinal regions. The lymph node at both groins was punctured under sonography guidance with the 25-gauge needle. Contrast material (lipiodol) which was heated (up to 37°C) to reduce viscosity was injected with a recommended volume of 0.2-0.4 ml per minute. When lymphatic vessels were opacified, we found lymphatic lesion at the right iliac fossa: a lymphatic vessel at the right iliac fossa enlarged like multi fusiform lymphatic aneurysms. From the biggest aneurysm, there was an extravasation of lymph directly into the peritoneal cavity ( Figure 2 ). Our diagnosis was that the patient had multi fusiform lymphatic aneurysms and there was a rupture of the biggest aneurysm into the abdomen cavity. The lymphatic aneurysms may result from the reflux of lymph within the vessel valves' pathology.
Figure 2: Lymphatic aneurysm and lymphatic extravasation; A lymphatic vessel is enlarged to the size of multi fusiform aneurysm (long arrow) and the presence of extravasation contrast in the peritoneal cavity (arrowhead) (A); Normal pattern of lymphatic channels at the left area (B); A 22-gauge-needle was punctured under guidance of DSA to perform embolization (arrow) (C)
To occlude the ruptured aneurysm, a needle (Chiba 22 G, Cook) was percutaneously punctured under the guidance of fluoroscopy into the lymphatic aneurysm. We then injected 5 ml contrast (Xenetic 350) through the needle to affirm that the tip of the needle was placed in the aneurysm. A guide wire 0.014" (transcend 14, Boston Scientific) was inserted into the lymphatic aneurysm through the needle. Through the guide wire, the 4-French-sheath was cannulated. One coil (5/20 mm, Axium 3D, EV3) was pushed into the aneurysm through the sheath. After that, we injected 10 ml mixture of n-butyl cyanoacrylate (NBCA) which was diluted with lipiodol at the ratio 1:2. After the procedure, the drainage still came out about 1 litre per 24 hours during 2 days. Abdominal CT scanner showed that the lymphatic aneurysm was partially filled with an embolic agent; where remained some compartments that were not filled with embolic agents (Figure 3) . For those reasons, we decided to do the second intervention. The second procedure was performed after 2 days. Because the aneurysm was still opacified, we punctured it with a 22-G needle under fluoroscopy. When the needle tip was in the aneurysm, we injected the sclerosis agent with the expectation that the https://www.id-press.eu/mjms/index inflammation reaction within the aneurysm can collapse all the compartments and heal the fistular. The sclerosant used was lauromacrogol 400 (Aetoxisclerol 2%-KreusslerPharma, France) (10ml mixture of foam solution containing 2ml of laucromacrogol and 8 ml of air). Finally, we embolized the lymph node by a technique that was described as "closet upstream lymph node embolisation" in the literature [2] ; 1 ml of NBCA (history/lipiodol 1:6 ratio) was injected into the lymph node at the right groin. After the second intervention, the amount of fluid leakage decreased significantly (Figure 4 ).
Figure 4: The amount of fluid drainage decreased after the first and second intervention
The patient was discharged one week later when the drain was empty. After six months, computed tomography revealed no more abdominal fluid, but there were still some retroperitoneal lymphatic aneurysms along the right iliac vessels that were not indicated for interventions, the patient was still under supervision ( Figure 5 ).
Figure 5: CT scanner of the patient before (A) and after treatment (B) showed a significant decrease of abdominal fluid; Some lymphatic aneurysms (arrow) before and after the intervention still endure, but there is no complication recognised, no further interventions have been indicated

Discussion
A lymphatic aneurysm is defined as a focal dilatation of lymphatic vessels with inflow and outflow to the normal lymphatic vessels (Figure 2A ). It can appear during a long time of reflux of the lymph into the peripheral lymphatic vessels. Percutaneous injection of the ruptured aneurysm was performed with a 22-gauge Chiba needle. The needle was punctured into the aneurysm revealed by lymphatic fluid coming out of the needle. The mixture ratio of NBCA and lipiodol was about 1:1 or 1:2 that was injected in the aneurysm. The injection time was about 10-30 seconds before the removal of the entire system. In our patients, we noticed that the leakage was high flow when injecting the contrast, so we decide to put coil before NBCA to prevent the unexpected migration of glue.
The fibrous agent used was lauromacrogol 400 (Aetoxisclerol, France) which destroyed the inner layer of the aneurysm or lymphatic vessels. Some studies have shown that sclerotherapy had a success rate of 77-90% for patients with lymphocele [6] , [7] . It is necessary for the sclerosant therapy to be combined with intravenous nutrition after 2-3 days to reduce volume of lymph in the lymphatic circulation and induce the effect of sclerosant. Some authors suggest to use somatostatin along with intravenous nutrition [1] , [8] . Somatostatin is a peptide hormone that is highly effective in patients with lymphatic leakage. The mechanism is supposed that it may reduce lymphatic production and concentrate the lymphatic liquid [8] .
The closest lymph node is the lymph node from which efferent extravasated vessels on lymphangiography ( Figure 6A) . A 26-gauge needle was punctured into the lymph node under ultrasound guidance to inject the embolic liquid NBCA. Depending on the flow velocity in the lymphatic vessels, the NBCA to lipiodol ratio was adjusted appropriately, usually from 1:3 to 1:9, according to the experiences of operator. The injection lasted for 10 -30 seconds so that the mixture filled the lymph node and entered lymphatic vessels [6] , [9] . In our patient, when injecting contrast media into the lymph node, we noticed the flow of lymph was slow. Therefore, we chose the ratio NBCA/lipodol at 1:2. [12] ; 21G Needle is punctured into lymphatic channels just under the pseudoaneurysm (B) The upstream lymphatic vessel is the vessel that goes directly into the lymphatic lesion on lymphangiography. It can be directly punctured with a 21-gauge needle [5] . Embolisation of this vessel can be done through the needle or a catheter by using glue NBCA. The ratio of historic/lipiodol was about 1:1.5 [2] (Figure 6B ). Percutaneous intervention may have potential risks including infection and bleeding. However, no damage has been recorded even with the usage of the largest needle like the 21 gauge [10] , [11] . The most severe complication that may occur in lymphangiography is pulmonary artery occlusion due to embolic lipiodol flowing to the thoracic duct and then to the right ventricular. To prevent the risk, lipiodol volume should be limited under 10 ml [2] , [5] , [6] . Contraindications of the lymphangiography include the patients with respiratory insufficiency and left-toright cardiac shunt.
In conclusion, intranodal lymphangiography with lipiodol is a revolutionary advance in the diagnosis of the lymphatic leakage. In our patient, this method is safe and effective. Also, percutaneous intervention to embolize the leakage with different embolic agents can become the first-line option as a less invasive, but highly effective method, which could replace the surgical treatment for patients.
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